0001493152-24-021454.txt : 20240528 0001493152-24-021454.hdr.sgml : 20240528 20240528073128 ACCESSION NUMBER: 0001493152-24-021454 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240528 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240528 DATE AS OF CHANGE: 20240528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTRICITY INC. CENTRAL INDEX KEY: 0001630113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 472548273 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40761 FILM NUMBER: 24986278 BUSINESS ADDRESS: STREET 1: 203 REDWOOD PARKWAY STREET 2: SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 832-1626 MAIL ADDRESS: STREET 1: 203 REDWOOD PARKWAY STREET 2: SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: METASOLUTIONS, INC. DATE OF NAME CHANGE: 20150107 8-K 1 form8-k.htm
false 0001630113 0001630113 2024-05-28 2024-05-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): May 28, 2024

 

BIOTRICITY INC.

(Exact name of registrant as specified in its charter)

 

Nevada   001-40761   30-0983531

(State or Other Jurisdiction of

Incorporation or Organization)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

203 Redwood Shores Parkway, Suite 600

Redwood City, California 94065

(Address of Principal Executive Offices)

 

(650) 832-1626

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Class   Trading Symbol (s)   Name of each exchange on which registered
Common Stock, Par Value $0.001   BTCY   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On May 28, 2024, Biotricity Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”) entered into an amendment (the “Amendment”) to that certain At The Market Offering Agreement, dated March 22, 2022, between the Company and Wainwright, as sales agent, pursuant to which the Company may sell shares of its common stock (the “Shares”), from time to time through Wainwright. Among other things, the Amendment gives effect to the Company’s filing of a new registration statement on Form S-3 (File No. 333-279226) filed with the Securities and Exchange Commission on May 8, 2024, and declared effective on May 15, 2024 (the “New Registration Statement”), as supplemented by a prospectus supplement dated May 28, 2024, in connection with the offer and sale of an aggregate offering amount of $2,684,644 of Shares. The Shares will be issued pursuant to the New Registration Statement.

 

The foregoing description of the Amendment is not complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.

 

In connection with the filing of the Amendment, the Company is also filing the opinion of Sichenzia Ross Ference Carmel LLP regarding the legality of the Shares as Exhibit 5.1.

 

2

 

 

Item 9.01 Financial statements and Exhibits

 

  (d) Exhibits.

 

Exhibit

Number

   Description
5.1   Opinion of Sichenzia Ross Ference Carmel LLP
10.1   Amendment to the At The Market Offering Agreement, dated May 28, 2024, between Biotricity Inc., and H.C. Wainwright & Co., LLC
23.1   Consent of Sichenzia Ross Ference Carmel LLP (included in Exhibit 5.1)
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 28, 2024

 

  BIOTRICITY INC.
     
  By: /s/ Waqaas Al-Siddiq
    Waqaas Al-Siddiq
    Chief Executive Officer

 

4

 

 EX-5.1 2 ex5-1.htm

 

Exhibit 5.1

 

 

May 28, 2024

 

Biotricity Inc.

203 Redwood Shores Parkway, Suite 600

Redwood City, California 94065

 

Re: Securities Registered under Registration Statement on Form S-3 (File No. 333-279226)

 

Ladies and Gentlemen:

 

We have acted as legal counsel to Biotricity Inc., a Nevada corporation (the “Company”), in connection with the offering and sale by the Company of shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”), having an aggregate offering price of up to $2,684,644 to be offered and sold from time to time pursuant to a prospectus supplement dated May 28, 2024 (the “Prospectus Supplement”) and the accompanying prospectus dated May 15, 2024 (together with the Prospectus Supplement, the “Prospectus”) that form part of the Company’s registration statement on Form S-3 (File No. 333-279226) (together with the Prospectus, the “Registration Statement”) filed by the Company with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”). The Shares are to be sold by the Company through or to H.C. Wainwright & Co., LLC (the “Manager”), as sales agent and/or principal, in accordance with that certain At-The-Market Offering Agreement, dated March 22, 2022, as amended on May 28, 2024, by and between the Company and the Manager (the “Offering Agreement”), as described in the Prospectus Supplement.

 

In connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of (i) the Registration Statement, including the Prospectus Supplement, (ii) a specimen certificate representing the Common Stock, (iii) the Offering Agreement, (iv) the Amended and Restated Articles of Incorporation of the Company, as currently in effect, (v) the Company’s Amended and Restated Bylaws, as currently in effect, and (vi) certain resolutions adopted by the Board of Directors of the Company with respect to the Offering Agreement and the issuance of the Shares. We have also examined originals or copies, certified or otherwise identified to our satisfaction, of such records of the Company and such agreements, certificates of public officials, certificates of officers or other representatives of the Company and others, and such other documents, certificates and records, as we have deemed necessary or appropriate as a basis for the opinion set forth herein.

 

In our examination, we have assumed and have not verified (i) the legal capacity of all natural persons, (ii) the genuineness of all signatures, (iii) the authenticity of all documents submitted to us as originals, (iv) the conformity with the originals of all documents supplied to us as copies, (v) the accuracy and completeness of all corporate records and documents made available to us by the Company, (vi) the truth, accuracy and completeness of the information, representations and warranties contained in the records, documents, instruments and certificates we have reviewed; and (vii) that the foregoing documents, in the form submitted to us for our review, have not been altered or amended in any respect material to our opinion stated herein. We have relied as to factual matters upon certificates from officers of the Company and certificates and other documents from public officials and government agencies and departments and we have assumed the accuracy and authenticity of such certificates and documents. We have further assumed that the Shares will be issued and delivered in accordance with the terms of the Offering Agreement.

 

Based on the foregoing, we are of the opinion that the Shares have been duly authorized and, when issued and sold in the manner described in the Registration Statement, the Prospectus Supplement and the Offering Agreement, will be validly issued, fully paid and non-assessable.

 

1185 Avenue of the Americas | 31st Floor | New York, NY | 10036 T (212) 930 9700 | F (212) 930 9725 | WWW.SRFC.LAW

 

 

 

 

 

We are members of the bar of the State of New York. We express no opinion as to the laws of any jurisdiction other than the laws of the State of New York, and the federal laws of the United States of America. Insofar as the matters covered by this opinion may be governed by the laws of other states we have assumed that such laws are identical in all respects to the laws of the State of New York.

 

We hereby consent to the use of this opinion as Exhibit 5.1 to the Company’s Current Report on Form 8-K filed with the Commission on the date hereof, which is incorporated by reference into the Registration Statement, and further consent to the reference to us in the Registration Statement and any amendments thereto. In giving such consent, we do not hereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.

 

This opinion is intended solely for use in connection with the offer and sale of the Shares pursuant to the Offering Agreement and Prospectus Supplement and is not to be relied upon for any other purpose or delivered to or relied upon by any other person without our prior written consent. This opinion is rendered as of the date hereof and based solely on our understanding of facts in existence as of such date after the examination described in this opinion. We assume no obligation to advise you of any fact, circumstance, event or change in the law or the facts that may hereafter be brought to our attention whether or not such occurrence would affect or modify the opinions expressed herein.

 

  Very truly yours,
   
  /s/ Sichenzia Ross Ference Carmel LLP
  Sichenzia Ross Ference Carmel LLP

 

1185 Avenue of the Americas | 31st Floor | New York, NY | 10036 T (212) 930 9700 | F (212) 930 9725 | WWW.SRFC.LAW

 

 

 

 EX-10.1 3 ex10-1.htm

 

Exhibit 10.1

 

May 28, 2024

 

Biotricity Inc.

997 Lenox Drive, Suite 100,

Lawrenceville, NJ 08648

Attention: Waqaas Al-Siddiq, Chief Executive Officer

 

Dear Mr. Al-Siddiq:

 

Reference is made to the At The Market Offering Agreement, dated as of March 22, 2022 (the “ATM Agreement”), between Biotricity Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”). This letter (the “Amendment”) constitutes an agreement between the Company and Wainwright to amend the ATM Agreement as set forth herein. Defined terms that are used but not defined herein shall have the meanings ascribed to such terms in the ATM Agreement.

 

1. The defined term “Agreement” in the ATM Agreement is hereby amended to mean the ATM Agreement as amended by this Amendment.

 

2. The definition of Registration Statement in Section 1 of the ATM Agreement is hereby amended by deleting “(File Number 333-255544)” and inserting in its place “(File Number 333-279226)”.

 

3. The first sentence of Section 2(b)(vii) of the ATM Agreement is hereby amended and restated in its entirety as follows:

 

“Unless otherwise agreed between the Company and the Manager, settlement for sales of the Shares will occur at 10:00 a.m. (New York City time) on the first (1st) Trading Day (or any such shorter settlement cycle as may be in effect pursuant to Rule 15c6-1 under the Exchange Act from time to time) following the date on which such sales are made (each, a “Settlement Date”).”

 

4. The last sentence of Section 3(h) of the ATM Agreement is hereby amended and restated in its entirety as follows:

 

“The Company meets the transaction requirements as set forth in General Instruction I.B.1 of Form S-3 or, if applicable, as set forth in General Instruction I.B.6 of Form S-3 with respect to the aggregate market value of securities being sold pursuant to this offering and during the twelve (12) months prior to such time that this representation is repeated or deemed to be made.”

 

 

 

 

5. A new Section 3(bb) of the ATM Agreement is inserted as follows:

 

“Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Shares from the Manager pursuant to this Agreement, will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an “investment company” subject to registration under the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so as to reasonably ensure that it or its Subsidiaries will not become an “investment company” subject to registration under the Investment Company Act of 1940, as amended.”

 

6. The second sentence of Section 13 of the ATM Agreement is hereby amended and restated in its entirety as follows

 

“Notwithstanding anything herein to the contrary, the letter agreement, dated April 15, 2024, by and between the Company and the Manager shall continue to be effective and the terms therein shall continue to survive and be enforceable by the Manager in accordance with its terms, provided that, in the event of a conflict between the terms of the letter agreement and this Agreement, the terms of this Agreement shall prevail.”

 

7. The Company and Wainwright hereby agree that the date hereof shall be a Representation Date under the ATM Agreement and the Company shall deliver the deliverables pursuant to Sections 4(k), 4(l) and 4(m) of the ATM Agreement on or about the date hereof.

 

8. In connection with the amendments to the ATM Agreement set forth herein, the Company shall reimburse the Manager for the fees and expenses of Manager’s counsel in an amount not to exceed $15,000, which shall be paid on the date hereof.

 

9. Except as expressly set forth herein, all of the terms and conditions of the ATM Agreement shall continue in full force and effect after the execution of this Amendment and shall not be in any way be changed, modified or superseded by the terms set forth herein.

 

10. This Amendment may be executed in two or more counterparts and by facsimile or “.pdf” signature or otherwise, and each of such counterparts shall be deemed an original and all of such counterparts together shall constitute one and the same agreement. Counterparts may be delivered via electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

 

[remainder of page intentionally left blank]

 

2

 

 

In acknowledgment that the foregoing correctly sets forth the understanding reached by the Company and Wainwright, please sign in the space provided below, whereupon this Amendment shall constitute a binding amendment to the ATM Agreement as of the date indicated above.

 

  Very truly yours,
     
  H.C. WAINWRIGHT & CO., LLC
     
  By: /s/ Edward D. Silvera
  Name:  Edward D. Silvera
  Title: Chief Operating Officer

 

Accepted and Agreed:  
     
biotricity Inc.  
     
By: /s/ Waqaas Al-Siddiq  
Name: Waqaas Al-Siddiq  
Title: Chief Executive Officer  

 

[signature page to btcy Amendment to atm agreement]

 

3

 

 GRAPHIC 4 ex5-1_001.jpg begin 644 ex5-1_001.jpg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end EX-101.SCH 5 btcy-20240528.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 btcy-20240528_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 7 btcy-20240528_pre.xml XBRL PRESENTATION FILE EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://biotricity.com/role/Cover Cover Cover 1 false false All Reports Book All Reports btcy-20240528.xsd btcy-20240528_lab.xml btcy-20240528_pre.xml form8-k.htm http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "BTCY", "nsuri": "http://biotricity.com/20240528", "dts": { "schema": { "local": [ "btcy-20240528.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "btcy-20240528_lab.xml" ] }, "presentationLink": { "local": [ "btcy-20240528_pre.xml" ] }, "inline": { "local": [ "form8-k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://biotricity.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-05-28", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-05-28", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 17 0001493152-24-021454-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-021454-xbrl.zip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

5&WQ1?;(/K M@QZAZKY!MWP9=@;=R'$0D<)8CDYA^3OR%SDD,@2TR,#(T M,#4R.%]L86(N>&ULS9U=;^.X%8;O"_0_<-V;%AC'$P(I M/8KX9EB%BPQGV[2J[>/N8_FG"/]$$_9TIOY:X90@>;Q8>K9+D_.1VF^YV]>3 M(R[6D^G'C\>3?_YRO8@>R0:/$Z:.6T1&.DK58HL[/CT]G>2E6MI2[E:"ZGV< M3+2=JF99FG3H:T[2Y"S-[5WS"&=YM_?N!H$*];^QEHW5IO'Q='QR?+1+XY$^ M^/D1%)R2>_* \F:>9?MGB5*:*!)&Y;9'01[L9J@0$Q4_862-,Q*K'9VJ'1W_ M0^WH+^7F:[PB=(244O(!MNNT45<9-'%M]HZ(A,>7['VNS6A/]N5W1V3_0P/J M\E:Y/_%=M:V_.;#:S^N5&V\ MEI\:%LDNDQ,8B;5)547'")SO(9\8RKJKVGG4J)>JT9R+=MO5S)C7F9+H:,U? M)C%)9-W3$_5AK#[DS9;_^6/&Y4K@8I5F D>9KBEOQOG(4CXQ+2GEA="^L(AZ M&E!O9[ MLD[4U*(LJ/-;HC9V#&. WO70WVG;G NLXB"@&>(0G"WJ0:B*\L31!6-;3._) M,Q==^#1EKJFQF31AJ6N"8L1B#$2CT*)"[(F(7[?RC)T(NN^%HJ5TS05@U43# MD 5%A]T;"$@E]\O(4F"6)FH ZX6D+75^N@&8;9UZ&+J@. ',P: MENTN?BIQL B9#@=2E(>)I-IMB!Z&6DK7] !636X,65#$V+V!K!1RE.O] M0W+)XD&(5#H_@!@V[7B4H@#A:#KK0T.J?8)QE:01IH67*[DM[6B>1>L:$-"N M"4E+&!0HD#L0EB) ,Y.'> 7F7P2+8;C4E'Y@:5FUHU+) @3%]-:'B=)[@62V M%:+A&IYQ8*FSF[(]9JO[LX N"%!ZS+7NVA;R!BB>9J!+EB797CU/=[/=K(BP M-*XM<<4&9$XS898'P0)@RF2@D"&E0X702\_KNP0L4P\Q@LTQ96X)L)ML4M#4 M!$2"U1A PT&;/U/JA8B9')D$IG,6D]W/9 ^VJZ5SRP1@LPF%(0J("KLS (M2 MC'(UDG(O8-R)9(/%?I%$/5-%6^@6#XPXULY M .YG/(97*#U1;J$:U(0F6ITA 0$VQ"> 62/T0_%,"N+J/9Z\ J1J\$+<11S+ M Y66_UPGC!R#[;=JW=+58;?)E$48$$FP.X"?4OE!?T J!MVR4*"9OJ&I4__0 M3(=",PT:FNE[H%F^\D"@.7E#4T_\0W,R%)J3H*$Y>1%L4.D%F;95*S '67BXM+SUP:("U'I&A?C$)%]8W8H[P5\2%L%+9DCN!1C MM)4:0QL>.G:#??Q4"V(=YW6L*1;EO5\2+?,SRC1-VH>80A,>)$UCO8-+H?:) MQ!U/,TS_G3QWGHC;Q5[PL!JV0M)0AH>*S5X?,$4,DD$^3JQ+7-4-#>NK9$:Y MNU> +;8.KP#7"H. P.:H_0IP^0,?D"@+7'5TY YW=MF>1 ]#I@R>SV7H5SGZ6J\ MRC"1VH?O6IFSF=VT4TWDNB"(WC7=M*9I7>ZX-W\322;W/..;S9:5=WELSPT" M.E>]W&E3][A5%$3O=SDS22BUJ"EVC,6"TR1*LH2M?Y$GGR+!ME;91*Z @ UJ M&MJ*(% ;9D<'(1(*QU#<">(@I#(CLA? E2)A<3MPX-UMN\2NX*BW["& U8& M 4FO/1,6&3".:A&H"$%YC%]LYFFZ)>)-\%A"/"$$F@= :NE#Q DRV0M5$>B3 MK06)MG)^W!]/5\LDH[:3R[;$V9P$F*MF)*,\"#8 4R8+>1GB#^AX^M?5WY". MN]AO5IP"V:>L*E<0=%C4'%@D0: ^S)IN.&HE*)"ZR,[5<.L MI3E&N2L K+9TUS<*@^ATFZ/6E[_1UYZ&_,M=]"A-$>"%!+O,]=!O,VD._W5- M$ AT&&N=E)12I+4^7D@X3%GK_D7 VMLB8-VS"%B'N A8#UT$K+TM O1NBQ0A MMM)9%TKF:&"FU:RZV<9*1N#!SE3#,H@33 M*CVB[8IX?X@S6@::K\#IT8?!T#"3+9R*,)W+L H\I+IT?2F]> #C-T+ISXR_ ML@7!*6O=/C'38[OYT P@#@*G(0Z!1V=4T/A)12$=5EX)\T+2 M-TZW+,,B?Y=6',!FDQA#%! I=F< (948%6H_+V@7V2.J15;QNT-@ M R&YX]>U.TT;;VU;M0$QTVD0>H>[S/EQ6!L749Y>L2N7ZKL,FV^36G3!H10IT'P_=MFC"2PA.1H7++@M5BDX6&)" 6;+X M%G(ITEHO+%QNB%C+Z>TGP5^SQS(_*]@V0.V6C4[+34:LTH!8Z?(',*-#4!&C M4^KZ@6=W2"A>9%F$6VJ1.L8&-&LPT]*%! QDKD4+)9&ZWG+#,[3DZ&M*4/9( MT&7Y,W3U3/!%/;Y^:22*U L1Q:J;F&=D [[MT!_BBJ"AYC5'??H@:!IHTF0J#VN>7.>! M2$7ZS&943VX/+_$:(L MP-MMEJH95!J#KX)W!CF^O3"@ <9-AHZ(@- ;8!.ZX9!'HCST RJ"42W:T_E9 M>L@"2.+/^WOR0(1Z[V!)=MEGN:.GCC., ;&NS]X&-\<\F>L-# +"M[J%3O52 M5*\ K=0S8F45Z'=5"7W3M?PD-^M-\J\53HG<\E]02P,$% @ M[3N\6/SH*O]:!P V5< !4 !B=&-Y+3(P,C0P-3(X7W!R92YX;6S-G%US MVC@4AN]W9O^#E[TF!&AWFS393DI#AVG:9$/:[NY-1]@"-)$E1I(#_/N5;$SY ML.23&Y_D(B'FU# :M2)MB$@(EX)>MH1LO?OKUU\B^W/Q6[L=#1GER7GT0<;MD9C*M]$7DM+S MZ",55!$CU=OH&^&9VR*'C%,5#62ZX-10^T71\'GT^J37FT3M-J#>;U0D4GV] M'VWKG1NST.>=SG*Y/!'RB2RE>M0GL4QA%8X-,9G>UG:Z.MW\%,4O.!./Y^[7 MA&@:65Y"GZ\TNVRY=C?-+OLG4LTZO=/3;N>?SS?C>$Y3TF;"<8MIJRSE:JDJ MUST[.^ODWY;2(^5JHGC91K]3=F=;L_V6!?0[/='L7.?=NY$Q,7G8:YN)O KW M7[N4M=VF=K?7[G=/5CIIE?!S@DIR>D^GD?MKH[=M=<*D42QF9NU"UG%?=P;2 M[I*VKWG!N:+3R];$Q&M;?^_5Z>O>&U?[[WLBLU[875,SMV>UHLY>RPM%-14F M-WMC-^P5H2MC=RB:E!6Y]N%],\PX^6:'Z49MMW=EJ6W-?BR4FZZ4G>$RWFN? MNRC( [/E'IVSUC0^F/;.$^53'UT-B2DIZ.[H&P3S="\LNTGK@]#3F;5. \D0)Y=#*"5;K"( M?J Z5FSAN-2 W5,"^?90^59X:QAS>>S8O*N\(6'^.R/*4,77$-)'8B#LUYBP/0Z1 M>#\H(C1S?"# C]5 XG^@7GAX/"(A'\\IYRZ-(P*TEU?I@=C_Q,3N]_D"P%\_ MN?.[/;7 V>\4 >)_\U+P'[E%BL =54PF]I2N .R/Q$#J9YC4/0Y1>5^+!$I[ M*P7G/_BP#^PAH1XR'1->]&AHM^DP[@HY%#E*SEEK$Q7[OY0H,/0=,10Y2AI: M8[%AX(-,J;W.!$<5OQJ*'"4!K3/9,/-K89A9N_O^7[)T\O/&Z3[K8Q64,4K2 MZ3.%PK:\TR",>YP1XGNHA#)&R35#YE X#ZP?1?A()'3UB:Y#H(^D4-(H.6;0 M'@KJ.\52HM9C%MNK<(E#U*6@FR MBQ*"D8BE6LB=V\4#F=GC<3V027!(KRD(#0=*OOD,ZRA!N4H2BTMO_MPP0;NA M4%3*P<^(\ (0L/E"L/>>A[T'QXZ2A];:?"'8^\_#WH=C1\E%:VUB8A_8C[?J M02X]3Z"]8BARE%RTQB(F\/Q, M>-U48NT]]'>^!L]@0QE6#VTTC/&[8L;V8"#3-!.;>S2>IV(>*10O2OH7M-

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form8-k_htm.xml IDEA: XBRL DOCUMENT 0001630113 2024-05-28 2024-05-28 iso4217:USD shares iso4217:USD shares false 0001630113 8-K 2024-05-28 BIOTRICITY INC. NV 001-40761 30-0983531 203 Redwood Shores Parkway Suite 600 Redwood City CA 94065 (650) 832-1626 false false false false Common Stock, Par Value $0.001 BTCY NASDAQ false XML 21 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover
May 28, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 28, 2024
Entity File Number 001-40761
Entity Registrant Name BIOTRICITY INC.
Entity Central Index Key 0001630113
Entity Tax Identification Number 30-0983531
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 203 Redwood Shores Parkway
Entity Address, Address Line Two Suite 600
Entity Address, City or Town Redwood City
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94065
City Area Code (650)
Local Phone Number 832-1626
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, Par Value $0.001
Trading Symbol BTCY
Security Exchange Name NASDAQ
Entity Emerging Growth Company false